Syn, berøring og barn
Speki. Nordic Philosophy and Education Review · 2025
DOI: 10.5617/speki.11544 ↗Kurz gefasst
Fachartikel in der Zeitschrift Speki. Nordic Philosophy and Education Review, 2025. Verfasst von Sigurd Hverven. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The article presents a phenomenological examination of the sensory experiences of sight and touch, drawing insights from Hans Jonas. It starts by establishing four key assumptions: 1) Historically, most Western philosophers have had limited engagement with the experiences of children. 2) Western philosophical discourse has predominantly adopted an adult-centric viewpoint. 3) While touch holds greater significance for children, sight has a more prominent role in adult experiences. 4) Sight has traditionally, within Western philosophical discourse, been considered as superior to other senses. Subsequently, the article conducts a phenomenological exploration of sight and touch, elucidating their philosophical ramifications. It posits that a deeper consideration of children's experiences could have prompted Western philosophers to engage more profoundly with the significance of touch and its philosophical implications, potentially counterbalancing the prevalent visual bias. Concluding with a speculative suggestion, the article contemplates the hypothetical philosophical consequences of such a tactile turn, suggesting a possible reorientation away from substance dualism, ontological atomism, and epistemological idealism towards process ontology and epistemological realism.
Zitieren
APA
Hverven, S. (2025). Syn, berøring og barn. Speki. Nordic Philosophy and Education Review. https://doi.org/10.5617/speki.11544
Vancouver
Hverven S. Syn, berøring og barn. Speki. Nordic Philosophy and Education Review. 2025. doi:10.5617/speki.11544
BibTeX
@article{Hverven2025,
author = {Hverven, Sigurd},
title = {Syn, berøring og barn},
journal = {Speki. Nordic Philosophy and Education Review},
year = {2025},
doi = {10.5617/speki.11544}
}
EUVIMED